QNTM — Quantum Biopharma Ltd. Class B Subordinate Voting Shares
QNTM (Quantum Biopharma Ltd. Class B Subordinate Voting Shares) stock: $3.66, $29.6M market cap, $1.9M cash, $27.7M EV, $15.2M fully diluted market cap. Data from Fully Diluted's biotech stocks database.
Share price
$3.66
Market cap
$29.6M
Cash
$1.9M
Enterprise value
$27.7M
Balance sheet
Cash
$1.9M
Debt
$0.0M
Net cash
$1.9M
Enterprise value
$27.7M
Basic shares
8.1M shares
Fully diluted shares
4.1M shares
Fully diluted market cap
$15.2M
Cash per share
$0.24
Cash figures as of 2025-12-31. Database snapshot: 2026-09-21.
Price history
Loading QNTM daily closes…
Loading price history…
Pipeline assets
Lucid-21-302
Preclinical · Active
Aliases Lucid-MS
Target PAD2/PAD4
Partnerships University Health Network (UHN License for pharmaceutical-purpose patents/IP associated with Lucid-MS)
Indications
Multiple sclerosis (MS)(Preclinical)
Status note Advancing towards human Phase 2 efficacy trials.
FSD-PEA
Stage not disclosed · Active
Partnerships Epitech (Epitech License Agreement for pharmaceutical-purpose IP associated with FSD-PEA)
Indications
Alcohol misuse(Stage not disclosed)
Status note Product candidate for alcohol misuse in the healthcare area; development stage not disclosed in the filing.
Per-asset detail extracted from the 20-F filed 2026-03-26. Fields the filing does not state are marked "not disclosed" rather than filled from other sources.
No lead program on file for this company.
No active ClinicalTrials.gov trials matched to this company as sponsor or collaborator.
No specialist-fund holders in 13F data for this company.
Get the weekly biotech catalyst rundown. Cash runways, financings, and trial readouts for all 714 stocks.